Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin Sotirios N. Sotiriou † , Valeria V. Orlova * ,† , Nadia Al-Fakhri ‡ , Eveliina Ihanus § , Matina Economopoulou * , Berend Isermann † , Khalil Bdeir || , Peter P. Nawroth † , Klaus T. Preissner ¶ , Carl G. Gahmberg § , Marlys L. Koschinsky ** and Triantafyllos Chavakis * ,† ,1 * Experimental Immunology Branch, NCI, NIH, Bethesda, Maryland, USA; † Department of Internal Medicine I, University Heidelberg, Heidelberg, Germany; ‡ Department of Clinical Chemistry and Molecular Diagnostics, Philipps-University, Marburg, Germany; § Division of Biochemistry, Faculty of Biosciences, University of Helsinki, Finland; || Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; ¶ Institute for Biochemistry, Justus-Liebig-University, Giessen, Germany; and ** Department of Biochemistry, Queen's University, Kingston, Ontario, Canada 1 Correspondence: Experimental Immunology Branch, NCI, NIH, 10 Center Drive, Rm. 4B17, Bethesda, MD 20892, USA. E-mail: chavakist@mail.nih.gov <h3>SPECIFIC AIMS</h3> Lipoprotein(a) [Lp(a)], consisting of LDL and apolipoprotein(a) [apo(a)], which contains multiple repeats resembling plasminogen kringle 4, is considered a risk factor for the development of atherosclerotic disorders, however, the underlying mechanisms for the atherogenicity of Lp(a) are not completely
/lp/fed-of-american-socs-for-experimental-biology/lipoprotein-a-in-atherosclerotic-plaques-recruits-inflammatory-cells-37ChN7ViCG